Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Biochem Pharmacol. 2010 Sep 30;81(1):104–110. doi: 10.1016/j.bcp.2010.09.015

Figure 2. Cytotoxicity of JC21, JCH, JC21LHRH, and JCHLHRH to prostate cancer cells.

Figure 2

(A) PC-3 cells were exposed to JC21, JC21LHRH, or JCHLHRH (0–20 µM). (B) LnCaP cells were exposed to JC21LHRH and JCHLHRH. C) DU-145 cells were exposed to JC21LHRH or JCHLHRH. Cell viability was determined by MTT. Mean ± s.d. (n=4)